Related Experiment Videos
Dramatic response to single-agent rituximab in a patient with intravascular lymphoma
American Journal of Hematology
|July 27, 2007
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas.
Journal of hematology & oncology·2026
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026.
Journal of the National Comprehensive Cancer Network : JNCCN·2026
American Society of Transplantation and Cellular Therapy Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma.
Transplantation and cellular therapy·2026
No BCMA? No Problem: A CD70-Targeting CAR-NK Cell Shows Promise in High-risk Myeloma.
Blood cancer discovery·2025
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.
American journal of hematology·2026
Clinically Relevant Outcomes With Romiplostim in Patients With Solid Tumors and Persistent Chemotherapy Induced Thrombocytopenia.
American journal of hematology·2026
The thrombotic burden of high-risk immune thrombocytopenia patients receiving second-line treatments: a systematic review.
Rheumatology (Oxford, England)·2026
Immune cell development from human pluripotent stem cells.
Stem cells (Dayton, Ohio)·2026
Surgical outcomes of ipsilateral in-situ versus contralateral or free internal thoracic artery grafting in dialysis-dependent patients with upper-extremity arteriovenous fistulas undergoing coronary artery bypass grafting.
Interdisciplinary cardiovascular and thoracic surgery·2026
Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome.
Cancer immunology research·2026
Editors Highlights-October 2026.
International journal of dermatology·2026